Company Entia Biosciences, Inc. Other OTC
Equities
ERGO
US29384E1047
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
Dietary Supplements, Nutraceuticals and Medical Foods Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -23.48% |
Sales per region
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -23.48% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 67 | 15-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 33,660,947 | 33,660,947 ( 100.00 %) | 0 | 99.44 % |
Stock B | 0 | 188,563 | 0 | 0 |
Company contact information
Entia Biosciences, Inc.
13565 SW Tualatin-Sherwood Road Suite 800
97140, Sherwood
+
http://www.entiabio.comSector
1st Jan change | Capi. | |
---|---|---|
+67.53% | 62.86B | |
-0.77% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.30% | 26.46B | |
-22.79% | 18.9B | |
+4.70% | 12.67B | |
+24.10% | 12.27B | |
+27.41% | 12.07B |